What sector does CTC BIO, INC. belong to?

CTC BIO, INC. operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 060590?

As of the latest available quote, 060590 traded at ₩3,100.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 060590?

CTC BIO, INC. has a price-to-earnings (P/E) ratio of about 22.63. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 060590?

The market capitalisation of CTC BIO, INC. is approximately ₩73.33B.

Is CTC BIO, INC. profitable?

For its latest reported financial year, CTC BIO, INC. recorded a net profit margin of about 2.62%.

What is the return on equity (ROE) of 060590?

CTC BIO, INC. has a return on equity (ROE) of about 4.46%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 060590?

Over the past 52 weeks, 060590 has traded between a low of ₩2,570.00 and a high of ₩7,570.00.

CTC BIO, INC.

060590 KRX Pharmaceuticals Pharmaceuticals

KOSDAQ

₩3,100.00

+0.16%

Delayed · cached 15 min

Fair value analysis

060590

CTC BIO, INC.

₩3,100.00

Close used for this calculation

₩2,357.81Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

29/100

Profitability4/25

Returns5/25

Balance Sheet14/25

Efficiency6/25

Growth0/25

Weak

Quality radar

Consensus fair value

₩2,357.81

Above FV

▼ -23.9% against the close used

Model range ₩633.89 – ₩3,060.78

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩633.89Fair value₩2,357.81Bull₩3,060.78

FairClose

52-week traded range

52W low ₩2,700.0052W high ₩3,365.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

CTC BIO, INC. closed at ₩3,100.00, 31.5% above the consensus fair value of ₩2,357.81 drawn from 7 valuation models.

Financial DNA score 29/100 — Weak. P/E of 22.6x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩2,849.94

-8.1%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₩3,060.78

-1.3%

√(22.5 × EPS × BVPS)

EPS=137, BVPS=3039.22 · outside Graham range (P/E 22.6, P/B 1) — asset-light, treat as a rough floor

P/E Fair Value

₩2,740.00

-11.6%

EPS × 20x (sector P/E)

EPS=137, Sector P/E=20x

EV/EBITDA

₩1,521.79

-50.9%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=6.25B

Book Value (P/B)

₩633.89

-79.6%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=3039.22, ROE=4.5%, g=3%, r=10%

Reverse DCF

₩3,100.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 8.8% | Historical: 0%

Margin of Safety

₩2,162.68

-30.2%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=2883.57, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer